About SIRENADE Pharmaceuticals

About company

SiREEN AG is a drug development start-up company that uses an integrated system of molecular tools to develop novel small molecule inhibitors. The company was founded by experts for molecular biology, protein crystallisation, medicinal chemistry, and medicine. SiREENs technology is designed to identify and improve highly specific molecules which inhibit the function of disease related proteins. SiREEN focuses on diseases that display an unmet medical need and large market potential. SiREEN currently runs programs in colon cancer, leukemia and neuroregeneration. SiREEN AG is based in Martinsried, Germany.